Flagship Harbor Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.44M | Sell |
50,083
-627
| -1% | -$73.4K | 0.25% | 99 |
|
|
2026
Q1 | $6.1M | Sell |
50,710
-3,429
| -6% | -$396K | 0.27% | 93 |
|
|
2025
Q4 | $5.7M | Sell |
54,139
-5,338
| -9% | -$501K | 0.27% | 88 |
|
|
2025
Q3 | $4.99M | Sell |
59,477
-1,046
| -2% | -$86.2K | 0.22% | 108 |
|
|
2025
Q2 | $4.79M | Buy |
60,523
+7,826
| +15% | +$622K | 0.23% | 105 |
|
|
2025
Q1 | $4.73M | Buy |
52,697
+5,099
| +11% | +$476K | 0.25% | 88 |
|
|
2024
Q4 | $4.74M | Buy |
47,598
+3,410
| +8% | +$352K | 0.25% | 82 |
|
|
2024
Q3 | $5.02M | Sell |
44,188
-322
| -0.7% | -$38.3K | 0.28% | 78 |
|
|
2024
Q2 | $5.51M | Buy |
44,510
+3,838
| +9% | +$494K | 0.33% | 68 |
|
|
2024
Q1 | $5.37M | Buy |
40,672
+74
| +0.2% | +$9.12K | 0.34% | 63 |
|
|
2023
Q4 | $4.43M | Buy |
40,598
+177
| +0.4% | +$18.4K | 0.32% | 67 |
|
|
2023
Q3 | $4.16M | Buy |
40,421
+388
| +1% | +$41.8K | 0.35% | 67 |
|
|
2023
Q2 | $4.62M | Sell |
40,033
-305
| -0.8% | -$34.6K | 0.38% | 56 |
|
|
2023
Q1 | $4.29M | Buy |
40,338
+5
| +0% | +$540 | 0.4% | 63 |
|
|
2022
Q4 | $4.47M | Buy |
40,333
+845
| +2% | +$86.4K | 0.46% | 51 |
|
|
2022
Q3 | $3.4M | Buy |
39,488
+1,044
| +3% | +$93.2K | 0.39% | 62 |
|
|
2022
Q2 | $3.5M | Sell |
38,444
-268
| -0.7% | -$23.8K | 0.39% | 56 |
|
|
2022
Q1 | $3.18M | Buy |
38,712
+1,135
| +3% | +$89.5K | 0.31% | 76 |
|
|
2021
Q4 | $2.88M | Sell |
37,577
-2,485
| -6% | -$198K | 0.27% | 82 |
|
|
2021
Q3 | $3.12M | Hold |
40,062
| – | – | 0.33% | 71 |
|
|
2021
Q2 | $3.12M | Buy |
40,062
+1,466
| +4% | +$109K | 0.33% | 71 |
|
|
2021
Q1 | $2.84M | Buy |
38,596
+1,196
| +3% | +$88.2K | 0.32% | 75 |
|
|
2020
Q4 | $2.92M | Buy |
37,400
+2,126
| +6% | +$163K | 0.36% | 62 |
|
|
2020
Q3 | $2.79M | Sell |
35,274
-812
| -2% | -$63.6K | 0.38% | 56 |
|
|
2020
Q2 | $2.66M | Buy |
36,086
+6,203
| +21% | +$467K | 0.39% | 51 |
|
|
2020
Q1 | $2.19M | Sell |
29,883
-781
| -3% | -$61.4K | 0.44% | 46 |
|
|
2019
Q4 | $2.66M | Sell |
30,664
-83
| -0.3% | -$6.82K | 0.47% | 46 |
|
|
2019
Q3 | $2.47M | Buy |
30,747
+605
| +2% | +$48.5K | 0.48% | 42 |
|
|
2019
Q2 | $2.41M | Buy |
30,142
+1,066
| +4% | +$81.6K | 0.5% | 41 |
|
|
2019
Q1 | $2.31M | Buy |
29,076
+1,392
| +5% | +$104K | 0.47% | 44 |
|
|
2018
Q4 | $2.02M | Sell |
27,684
-1,158
| -4% | -$81.7K | 0.49% | 43 |
|
|
2018
Q3 | $1.97M | Sell |
28,842
-4,375
| -13% | -$279K | 0.37% | 62 |
|
|
2018
Q2 | $1.92M | Buy |
33,217
+1,747
| +6% | +$98.6K | 0.38% | 56 |
|
|
2018
Q1 | $1.6M | Buy |
31,470
+4,756
| +18% | +$257K | 0.48% | 58 |
|
|
2017
Q4 | $1.44M | Buy |
26,714
+1,498
| +6% | +$83K | 0.41% | 69 |
|
|
2017
Q3 | $1.54M | Buy |
25,216
+547
| +2% | +$33.2K | 0.5% | 53 |
|
|
2017
Q2 | $1.48M | Buy |
24,669
+307
| +1% | +$18.7K | 0.51% | 54 |
|
|
2017
Q1 | $1.48M | Buy |
24,362
+4,271
| +21% | +$259K | 0.56% | 47 |
|
|
2016
Q4 | $1.2M | Buy |
+20,091
| New | +$1.18M | 0.52% | 59 |
|
Other funds holding MRK
ECSS
ATO
Flagship Harbor Advisors's MRK Position: Q2 2026 in Review
Flagship Harbor Advisors reduced its Merck (MRK) stake by 1.2% in Q2 2026, selling an estimated $73.4K and leaving 50,083 shares worth $6.44M. The position accounts for 0.25% of the portfolio, ranked #99.
Flagship Harbor Advisors first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. 1,657 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Flagship Harbor Advisors held 50,083 shares of Merck worth $6.44M as of Q2 2026.
- Flagship Harbor Advisors sold 627 Merck shares in Q2 2026, an estimated $73.4K.
- Merck made up 0.25% of Flagship Harbor Advisors's portfolio in Q2 2026, its #99 holding.
- Flagship Harbor Advisors first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- 1,657 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.